OXAPROZIN Drug Patent Profile
✉ Email this page to a colleague
When do Oxaprozin patents expire, and what generic alternatives are available?
Oxaprozin is a drug marketed by Actavis Elizabeth, Amneal Pharms Co, Beximco Pharms Usa, Chartwell, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan Pharms Inc, Norvium Bioscience, Pangea, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs. and is included in thirteen NDAs.
The generic ingredient in OXAPROZIN is oxaprozin. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxaprozin
A generic version of OXAPROZIN was approved as oxaprozin by DR REDDYS LABS LTD on January 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXAPROZIN?
- What are the global sales for OXAPROZIN?
- What is Average Wholesale Price for OXAPROZIN?
Summary for OXAPROZIN
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,870 |
| Drug Prices: | Drug price information for OXAPROZIN |
| What excipients (inactive ingredients) are in OXAPROZIN? | OXAPROZIN excipients list |
| DailyMed Link: | OXAPROZIN at DailyMed |
Recent Clinical Trials for OXAPROZIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mochida Pharmaceutical Company, Ltd. | Phase 1 |
| Fuji Yakuhin Co., Ltd. | Phase 1 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for OXAPROZIN
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for OXAPROZIN
US Patents and Regulatory Information for OXAPROZIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | OXAPROZIN | oxaprozin | TABLET;ORAL | 075843-001 | Oct 3, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Pharms Inc | OXAPROZIN | oxaprozin | TABLET;ORAL | 075847-001 | Feb 28, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell | OXAPROZIN | oxaprozin | TABLET;ORAL | 075987-001 | Sep 2, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
